These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8237837)

  • 1. The European Myocardial Infarct Amiodarone Trial (EMIAT). EMIAT Investigators.
    Camm AJ; Julian D; Janse G; Munoz A; Schwartz P; Simon P; Frangin G
    Am J Cardiol; 1993 Nov; 72(16):95F-98F. PubMed ID: 8237837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.
    Julian DG; Camm AJ; Frangin G; Janse MJ; Munoz A; Schwartz PJ; Simon P
    Lancet; 1997 Mar; 349(9053):667-74. PubMed ID: 9078197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial. Canadian Amiodarone Myocardial Infarction Trial.
    Jafri SM; Borzak S; Goldberger J; Gheorghiade M
    Prog Cardiovasc Dis; 1998; 41(1):65-70. PubMed ID: 9717860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial).
    Malik M; Camm AJ; Janse MJ; Julian DG; Frangin GA; Schwartz PJ
    J Am Coll Cardiol; 2000 Apr; 35(5):1263-75. PubMed ID: 10758969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Gambhir DS
    Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
    [No Abstract]   [Full Text] [Related]  

  • 6. Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.
    Yap YG; Camm AJ
    Am J Cardiol; 1999 Nov; 84(9A):83R-89R. PubMed ID: 10568665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial).
    Janse MJ; Malik M; Camm AJ; Julian DG; Frangin GA; Schwartz PJ
    Eur Heart J; 1998 Jan; 19(1):85-95. PubMed ID: 9503180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databases. The EMIAT and CAMIAT Investigators.
    Boutitie F; Boissel JP; Connolly SJ; Camm AJ; Cairns JA; Julian DG; Gent M; Janse MJ; Dorian P; Frangin G
    Circulation; 1999 May; 99(17):2268-75. PubMed ID: 10226092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of patients with risk of sudden death. The amiodarone example].
    Djian J
    Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):67-74. PubMed ID: 7944868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arrhythmic risk stratification of post-myocardial infarction patients.
    Naccarella F; Lepera G; Rolli A
    Curr Opin Cardiol; 2000 Jan; 15(1):1-6. PubMed ID: 10666655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function.
    Pfisterer M; Kiowski W; Burckhardt D; Follath F; Burkart F
    Am J Cardiol; 1992 Jun; 69(17):1399-402. PubMed ID: 1590226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The azimilide post-infarct survival evaluation (ALIVE) trial.
    Camm AJ; Karam R; Pratt CM
    Am J Cardiol; 1998 Mar; 81(6A):35D-39D. PubMed ID: 9537221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.
    Cairns JA; Connolly SJ; Roberts R; Gent M
    Lancet; 1997 Mar; 349(9053):675-82. PubMed ID: 9078198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial).
    Milliez P; Leenhardt A; Maisonblanche P; Vicaut E; Badilini F; Siliste C; Benchetrit C; Coumel P;
    Am J Cardiol; 2005 Apr; 95(7):821-6. PubMed ID: 15781008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amiodarone and secondary prevention. The EMIAT study].
    Munoz A
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():67-9. PubMed ID: 1726998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-arrhythmia therapy after myocardial infarct: preliminary results of EMIAT and CAMIAT studies].
    Kuck KH
    Z Kardiol; 1996; 85 Suppl 6():107-13. PubMed ID: 9064953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS).
    Burkart F; Pfisterer M; Kiowski W; Follath F; Burckhardt D
    J Am Coll Cardiol; 1990 Dec; 16(7):1711-8. PubMed ID: 2254558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocker prevention of proarrhythmia and proischemia: clues from CAST, CAMIAT, and EMIAT. Cardiac Arrhythmia Suppression Trial. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial. European Myocardial Infarct Amiodarone Trial.
    Kennedy HL
    Am J Cardiol; 1997 Nov; 80(9):1208-11. PubMed ID: 9359552
    [No Abstract]   [Full Text] [Related]  

  • 19. Amiodarone and "primary" prevention of sudden death: critical review of a decade of clinical trials.
    Farré J; Romero J; Rubio JM; Ayala R; Castro-Dorticós J
    Am J Cardiol; 1999 Mar; 83(5B):55D-63D. PubMed ID: 10089841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.